newsfilter
← Latest News
Business Wire·

AlloVir to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

AlloVir (NASDAQ:ALVR), a late clinical-stage allogeneic T cell immunotherapy company, today announced that Diana Brainard, M.D., Chief Executive Officer, will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on